David Portnoy - 07 Jan 2026 Form 4 Insider Report for CRYO CELL INTERNATIONAL INC (CCEL)

Signature
/s/ David Portnoy
Issuer symbol
CCEL
Transactions as of
07 Jan 2026
Net transactions value
+$778,000
Form type
4
Filing time
09 Jan 2026, 17:00:15 UTC
Previous filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PORTNOY DAVID Chairman, Co-CEO, Director, 10%+ Owner 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR /s/ David Portnoy 09 Jan 2026 0001315416

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CCEL Common Stock 161,833 07 Jan 2026 By Corporation F1
holding CCEL Common Stock 164,182 07 Jan 2026 By 401K
holding CCEL Common Stock 268,878 07 Jan 2026 By IRA
holding CCEL Common Stock 107,403 07 Jan 2026 By Spouse
holding CCEL Common Stock 57,306 07 Jan 2026 By Corporation F2
holding CCEL Common Stock 59,027 07 Jan 2026 By LLC F3
holding CCEL Common Stock 847,629 07 Jan 2026 Direct
holding CCEL Common Stock 12,214 07 Jan 2026 As Custodian for son
holding CCEL Common Stock 11,804 07 Jan 2026 As Custodian for son
holding CCEL Common Stock 11,212 07 Jan 2026 As Custodian for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCEL Stock Option Award $194,500 +50,000 $3.89 50,000 07 Jan 2026 Common Stock 50,000 $3.89 Direct F8
transaction CCEL Stock Option Award $583,500 +150,000 $3.89 150,000 07 Jan 2026 Common Stock 150,000 $3.89 Direct F9
holding CCEL Stock Option 26,243 07 Jan 2026 Common stock 26,243 $7.53 Direct
holding CCEL Stock Option 23,636 07 Jan 2026 Common Stock 23,636 $7.28 Direct
holding CCEL Stock Option 280,000 07 Jan 2026 Common Stock 280,000 $12.27 Direct F4
holding CCEL Stock Option 50,000 07 Jan 2026 Common Stock 50,000 $4.77 Direct F5
holding CCEL Stock Option 50,000 07 Jan 2026 Common Stock 50,000 $4.30 Direct
holding CCEL Stock Option 50,000 07 Jan 2026 Common Stock 50,000 $6.47 Direct F6
holding CCEL Stock Option 50,000 07 Jan 2026 Common Stock 50,000 $8.08 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
F2 Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
F3 Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
F4 Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
F5 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
F6 Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F7 Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
F8 Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
F9 The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.